<p>It is intended to provide a drug for improving abnormal glucose tolerance or an antidiabetic drug comprising a GPR92/93 agonist as the active ingredient; a method of screening a drug for improving abnormal glucose tolerance or an antidiabetic drug depending on the fact that a test substance is a GPR92/93 ligand as an indication; and so on.</p>
